このエピソードについて

英語
イギリス

文字起こし 🔗

過去のエピソードを検索

Beyond Longevityの以前のエピソードを検索します。

このポッドキャストの他のエピソード

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy people understand what to change before disease develops. Some thought he was crazy. That idea b…
What if a vaccine could help the immune system clear senescent “zombie” cells — damaged cells linked to ageing, chronic inflammation and age-related disease? In this episode of Beyond Longevity, Daphna Stern sits down with David Scieszka, PhD, MBA, a biomedical scientist, computational biologist, a…
In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving from reactive, disease-led healthcare towards preventative, personalised medicine that tracks bio…
What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at once? In this episode, host Daphna Stern speaks with LinkGevity founders Dr Carina Kern and Seren…
免責: このページに埋め込まれているポッドキャストとアートワークは Daphna Stern からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。